Forskning
Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital
Udgivet

Defining NASH from a multi-omics systems biology perspective

Publikation: Bidrag til tidsskriftReviewForskningpeer review

DOI

  1. Incidence of COVID-19 Hospitalisation in Patients with Systemic Lupus Erythematosus: A Nationwide Cohort Study from Denmark

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Corticosteroid Resistance in Smokers-A Substudy Analysis of the CORTICO-COP Randomised Controlled Trial

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Language Development for the New Generation of Children with Hearing Impairment

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Glucagon Clearance is Preserved in Type 2 Diabetes

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Plasma GDF15 levels are similar between subjects after bariatric surgery and matched controls and are unaffected by meals

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Reply to Rodgers: The hepatic glucose-mobilizing effect of glucagon is not mediated by cyclic AMP most of the time

    Publikation: Bidrag til tidsskriftKommentar/debatForskningpeer review

  4. The glucose-mobilizing effect of glucagon at fasting is mediated by cyclic AMP

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Neprilysin inhibition increases glucagon levels in humans and mice with potential effects on amino acid metabolism

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

Non-alcoholic steatohepatitis (NASH) is a chronic liver disease affecting up to 6.5% of the general population. There is no simple definition of NASH, and the molecular mechanism underlying disease pathogenesis remains elusive. Studies applying single omics technologies have enabled a better understanding of the molecular profiles associated with steatosis and hepatic inflammation-the commonly accepted histologic features for diagnosing NASH, as well as the discovery of novel candidate biomarkers. Multi-omics analysis holds great potential to uncover new insights into disease mechanism through integrating multiple layers of molecular information. Despite the technical and computational challenges associated with such efforts, a few pioneering studies have successfully applied multi-omics technologies to investigate NASH. Here, we review the most recent technological developments in mass spectrometry (MS)-based proteomics, metabolomics, and lipidomics. We summarize multi-omics studies and emerging omics biomarkers in NASH and highlight the biological insights gained through these integrated analyses.

OriginalsprogEngelsk
Artikelnummer4673
TidsskriftJournal of Clinical Medicine
Vol/bind10
Udgave nummer20
ISSN2077-0383
DOI
StatusUdgivet - 12 okt. 2021

ID: 68712799